baber/WOPTO huggingface dataset:
Patent EP-1285984-A2 (EP)
Inventor: YAMADA SHIGEO
IPC: D03D51/08
Filed: 2002-07-19
Abstract: Aloom (1) is started for a normal weaving operation after shifting the
cloth fell (9) of a fabric (8) on the loom (1) to a desired position by driving
cloth fell shifting members (16, 19). A plurality of starting methods to be
used selectively are set for the loom (1) The plurality of starting methods
include a starting method that starts the loom (1) for a normal weaving
operation after turning the main shaft (22) of the loom (1) in a normal or a
reverse direction to a predetermined angular position different from an
angular position where the main shaft (22) is stopped at the present. One of
the plurality of starting methods is selected and is carried out to start the
loom (1), and the position of the cloth fell (9) is adjusted according to a
displacement, by which the cloth fell (9) is to be shifted, assigned to the
selected starting method.
Patent EP-1298027-A2 (EP)
Inventor: STEPHAN ANTON
IPC: B62D1/08
Filed: 2002-08-02
Abstract: Steering wheel for a motor vehicle comprises a steering wheel rim (2) that can change shape so that during its rotation the distance between a fixed point (X) on the rim on which the hand of the driver rests and a fixed support point of the driver's shoulder joint on the back rest of the vehicle seat changes by a smaller amount than in the case of a fixed shape steering wheel rim during the same steering movement. <??>Preferred Features: The steering wheel rim is divided into partial sections (2a, 2b, 2c) which move relative to each other.
Patent EP-1283264-A2 (EP)
Inventor: BAUER S CHRISTOPHER
IPC: C12N1/19
Filed: 1993-11-22
Abstract: The present invention relates to recombinant human
interleukin-3 (hIL-3) variant or mutant proteins
(muteins). These hIL-3 muteins contain one or more amino
acid substitutions and may also have amino acid deletions
at both the N- and C- termini. The invention also
relates to pharmaceutical compositions containing the
hIL-3 muteins and methods for using them. Additionally,
the present invention relates to recombinant expression
vectors comprising nucleotide sequences encoding the hIL-3
muteins, related microbial expression systems, and
processes for making the hIL-3 muteins using the
microbial expression systems. 
     Included in the present invention are deletion
mutants of hIL-3 in which from 1 to 14 amino acids have
been deleted from the N-terminus, and from 1 to 15 amino
acids (corresponding to residues 119 to 133) have been
deleted from the C-terminus, and which also contain one
to three amino acid substitutions in the polypeptide.
These hIL-3 mutant polypeptides may have biological
activities similar to or better than hIL-3 and, in some
cases, may also have an improved side effect profile.
Patent EP-1300940-A2 (EP)
Inventor: TAKADA TOSHIO
IPC: H03F1/32
Filed: 2002-09-27
Abstract: A distortion compensation circuit reduces an unbalance
between higher and lower 3rd order distortions, the
distortions being generated by an amplifier which amplifies
an input signal having at least two frequency components.
Amplitude modulation means, which includes an amplitude
detector, an amplitude circuit, a phase circuit and another
amplitude circuit, generates sideband signals corresponding
to an instantaneous phase difference between the higher and
lower 3rd order distortions, such that distortions generated
by the amplifier can be cancelled. Further, sideband signal
generating means, which includes an amplitude circuit, a
delay circuit, an AM modulator, another amplitude circuit,
another delay circuit and a PM modulator, performs AM and PM
on the input signal to thereby generate sideband signals,
such that distortions generated by the amplifier can be
cancelled.
Patent EP-1298609-A2 (EP)
Inventor: WEBB BAYARD S
IPC: G07F17/34
Filed: 2002-09-27
Abstract: The present invention provides a gaming device which includes a
plurality of symbols. A first selection is chosen from a first set of symbols. A
second reel is chosen from a second set of symbols. The first and second set
of symbols have a first characteristic and a second characteristic. A third or
modifier selection is chosen from a third set of symbols. The symbols in the
third set of symbols have at least a first characteristic. The award a player
receives includes a first characteristic component based on the first
characteristics of the first selection, second selection and third selection. The
award also includes a second characteristic component based on the second
characteristic of the first and second selections and a second characteristic, if
any, of the third selection.
Patent EP-1303040-A2 (EP)
Inventor: LOPEZ PATRICK
IPC: H04L27/38
Filed: 2002-10-01
Abstract: The method is applicable to a receiver (1) of signals corresponding to
packets of digital data transmitted in bursts, which comprises an analogue
pickup subassembly (3) connected to a digital processing subassembly
(8) by means for converting analogue signals into digital signals (7). Gain
adjustment means act on the amplification means (5) in order to alter
the power of signals supplied to the conversion means. 
The method provides a preadjustment of the gain, in the absence of a
burst, for detecting the arrival of signals even if they are weak, and an
adjustment of the gain as a function of a power value of the signal
determined from burst start symbols, as obtained after conversion. This
adjustment is dependent on the recognition of symbols scheduled at the
start of a burst, it is carried out during a time scheduled for a symbol
otherwise left unexploited by the method.
Patent EP-1282311-A2 (EP)
Inventor: EZAKI TADASHI
IPC: H04N7/083
Filed: 1993-10-07
Abstract: A data decoding device capable of decoding plural kinds of data superimposed in a vertical blanking period of a video signal. The device comprises means for detecting the line number and the intraline position in the vertical blanking period from vertical and horizontal sync signals and generating a line signal extract pulse, a data signal extract pulse and a reference signal extract pulse; binary circuit means for converting the video signal into a binary signal; PLL means for producing a data extract clock signal in synchronism with a clock reference signal extracted on the basis of the line signal extract pulse and the reference signal extract pulse; memory means supplied with the data extract clock signal and the binary signal in response to the line signal extract pulse and the data signal extract pulse, and storing the data signal therein; and control means capable of designating a plurality of durations for generating the respective extract pulses and a plurality of frequency division ratios in the PLL means. In the device, the circuits are usable in common to achieve curtailment in the production cost.
Patent EP-1316813-A2 (EP)
Inventor: PUGLIA KENNETH
IPC: G01S13/931
Filed: 2002-11-28
Abstract: A sensor front end for an electronic radar sensor
provides for a lower parts count while providing technical
functionality by using multifunction parts, i.e., parts
that are used both in transmitting and receiving. The
sensor front end includes a continuous wave signal source
(202) that functions as a signal source when the front end
is transmitting a signal and as a local oscillator when
the front end is receiving a signal. The sensor front end
also includes a tri-mode mixer (204) that functions as a
phase-modulator and transmit switch when the front end is
transmitting a signal and as a mixer/down-converter when
the front end is receiving a signal. The sensor front end
further includes a common aperture antenna (102) that acts
as both a transmitting antenna for transmitting a sensor
signal (121) and for receiving a reflected signal (123)
from an object (122). A phase shifter (206) is added to
provide a predetermined phase shift in the transmitted
sensor signal, the received reflected signal, or both,
such that in-phase and quadrature signal components are
provided. In addition, phase coding may be added to the
signal to reduce the degenerative impact of interfering
signals. A receiver module is coupled to the tri-mode
mixer (204) such that, when receiving a reflected signal,
the receiver provides a baseband sensor output signal that
can be used to determined the position and velocity of the
object (122). A sampling module can be added such that the
sensor output signal is sampled and provided as an analog
signal (118), or the sampled sensor output signal can be
provided to an analog-to-digital converter to convert the
sensor output signal into a digital format (120), or both.
Patent EP-1235212-A2 (EP)
Inventor: MASAMICHI TANAKA
IPC: G11B7/126
Filed: 2002-02-22
Abstract: A high-frequency superposition module for an
optical pickup that reduces the number of devices,
facilitates scale-down and allows an oscillating
circuit to be turned off when a power supply for
feeding a direct current to a laser diode is turned off
and an optical pickup using the high-frequency
superposition module. An oscillating circuit (12) for
feeding a high frequency to a laser diode (1) comprises
at least an active element and passive elements such as
capacitors, resistors, and inductors. A power supply
(13) for feeding a direct current to the laser diode is
also used as a power supply for the oscillating
circuit.
Patent EP-1414367-A2 (EP)
Inventor: LOSHAKOVE AMIR
IPC: A61B17/28
Filed: 2002-03-18
Abstract: L'invention se rapporte à un appareil conçu pour former un trou dans un vaisseau sanguin et comportant une tige de pénétration présentant une extrémité conçue pour être insérée à l'intérieur d'une paroi de vaisseau sanguin ; à un dispositif de retenue des tissus qui est conçu pour maintenir une partie de ladite paroi et peut être activé de manière à pratiquer l'ouverture séparément de l'insertion de ladite tige de pénétration dans ladite paroi ; et à une surface de coupe conçue pour découper la paroi.
Patent EP-1418969-A2 (EP)
Inventor: EFRATI SHAI
IPC: A61M16/04
Filed: 2002-03-21
Abstract: An intubation method and system including the insertion of an endotracheal tube into a patient airway, inflating an cuff associated with the endotracheal tube at a location in the patient airway below the vocal cords, monitoring carbon dioxide concentration in the patient airway at a carbon dioxide monitoring location between the cuff and the vocal cords and adjusting inflation of the cuff based at least in part on the monitoring in order that the cuff inflation generally prevents leakage of carbon dioxide past the cuff.
Patent EP-1372850-A2 (EP)
Title: Holding device, particularly for body fluids, comprising a separating device, and a separating device therefor
Inventor: KONRAD FRANZ
IPC: B01L3/14
Filed: 2002-03-28
Abstract: The invention relates to a holding device (1) provided with a holding receptacle (5), a closure device for an open end (6) of the same, a separating device (11), which is placed inside a holding space (117), and at least one flow channel (119) that can be closed. The separating device (11) can be displaced from a starting position into a working position that is located at a distance therefrom in the direction of another end (7). The separating device (11) comprises at least one part (121) that is pressed in areas against an inner wall (118) of the holding receptacle (5) by at least one pressing element (122). An inner measure (14) of the holding space (117) in a first plane (16) is greater than an outer measure (123) of the part (121) when in its working position and in the same direction in space. In the starting position, a flow channel (119) is formed between the ends (6, 7) of the holding receptacle (5) in the area of the separating device (11). In the area of the working position of the separating device (11), an inner measure (124) of the holding space (117) is equal to or less than the outer circumference of an outer line of the part (121) in the same position. When in a working position, the part (121) of the separating device (11) automatically seals the flow channel(s) (119).
Patent EP-1498399-A2 (EP)
Inventor: ACOSTA ECHEVERRIA ANSELMO
IPC: C04B35/636
Filed: 2002-01-31
Abstract: Due to its physicochemical and mineralogical properties,
precipitated calcium carbonate (PCC) of sugar origin can be
used as a raw material in the ceramic industry, particularly
in the manufacture of porous ceramics.
Patent EP-1386443-A2 (EP)
Inventor: KOBATA HIROSHI
IPC: G06F3/0481
Filed: 2002-05-10
Abstract: An electronic mail system (100) is modified to produce a secure delivery system by modifying a user interface (2710) of the electronic mail system (100) to present a secure delivery icon (2605) and causing the electronic mail system (100) to initiate a secure delivery response to actuation of the secure delivery icon (2605). The secure delivery uses a delivery protocol different (1170) from a protocol provided (1160) by the electronic mail system (100), and the secure delivery icon (2605) is presented in addition to a normal delivery icon (2620) of the electronic mail system (100).
Patent EP-1402273-A2 (EP)
Inventor: FICHERA STEPHEN L
IPC: G01N27/64
Filed: 2002-06-10
Abstract: A process and apparatus are provided for simultaneously moving a first sample plate into an analytical apparatus and a second sample plate from the analytical apparatus. The first sample plate is moved on an entry path which is vertically spaced apart from an exit path for the second sample plate. The transfer mechanism is disclosed in operation with a MALDI-TOF mass spectrometer.
Patent EP-1416982-A2 (EP)
Inventor: KIRCHHOFER FRITZ
IPC: A61M5/20
Filed: 2002-07-22
Abstract: An administering apparatus for delivering a dosage of product including a casing with a reservoir for the product, a piston within the reservoir to deliver the product, a piston rod for engaging the piston, a drive device for driving the piston rod, and a dosage setting member mechanically engaging the piston rod and a stopper for the dosage setting member. The casing includes a front casing section containing a reservoir for the product and a rear casing section detachably connected to the front casing section. The front casing section is connected to or forms a first latching element, and the rear casing section is connected to or forms a second latching element. The latching elements are in latching engagement when the casing sections are connected. The casing sections may be axially fixed to one another by the latching engagement. The casing sections may alternately be fixed to one another, secured against rotating, with respect to a rotational movement about a longitudinal axis of the casing sections parallel to the advancing direction, by the latching engagement. The administering apparatus further includes a latching block coupled to the drive element such that the latching engagement can only be released in a releasing position of the drive element.
Patent EP-1372538-A2 (EP)
Inventor: GALIN MILES A
IPC: A61F2/16
Filed: 2002-02-26
Abstract: De manière générale, l'invention concerne un implant oculaire à chambre antérieure réfractive, destiné à être placé dans l'angle anatomique d'un oeil phakique, l'implant comportant une lentille ou une partie optique artificielle avec une surface antérieure et une surface postérieure, qui possède une partie haptique destinée à mettre en prise et positionner la partie optique dans l'angle anatomique, la partie haptique possédant une plaquette d'extension qui s'étend et s'amincit depuis la partie haptique dans une direction axiale. L'invention concerne aussi des procédés pour corriger les erreurs de réfraction chez un patient ayant besoin d'une telle correction ayant un oeil phakique et un angle anatomique; les procédés consistent à implanter par voie chirurgicale un implant oculaire à chambre antérieure pouvant être supporté sous un angle et possédant une partie optique présentant des propriétés réfractives désirées et une partie haptique possédant une plaquette d'extension qui s'étend et s'amincit depuis la partie haptique dans une direction axiale, et à ancrer la plaquette d'extension dans l'angle anatomique de l'oeil.
Patent EP-1409672-A2 (EP)
Inventor: AL-MAHMOOD SALMAN
IPC: A61P1/04
Filed: 2002-06-14
Abstract: Angiogenesis-modifying composition (A) containing at least one of a nucleic acid (I) from the gene encoding IRS-1 (insulin receptor substrate-1), or its complement or fragments, or a molecule (II) that inhibits expression of the nucleic acid, is new. ACTIVITY : Ophthalmological; Antiarthritic; Antirheumatic; Antiinflammatory; Gynecological; Antipsoriatic; Cytostatic; Vasotropic; Hypotensive; Vulnerary; Antianginal; Cardiant; Osteopathic. Corneal wounds were made in rats as described in Invest. Ophthalmol. Vis. Sci., 39 (1998) 18, then the animals given a subconjunctival injection of a composition containing 60 MicroM of the oligonucleotide (3), antisense to the IRS-1 gene 5'-TATCCGGAGGGCTCGCCATGCTGCT (3) in buffered saline, every day from days 4 to 9. The animals were killed on day 10 and the degree of neovascularization determined by staining with fluorescein-dextran, photography under a fluorescent microscope and then the ratio of neovascularized surface to total corneal surface was calculated. This ratio was 0.6157 (n = 15) for treated animals, compared with 0.9552 (n = 9) for those injected with saline only and 0.9170 (n = 9) for untreated animals, indicating a statistically significant reduction in neovascularization caused by (3). Similar results were obtained by topical application of an ointment containing 200 MicroM (3). MECHANISM OF ACTION : Antisense gene therapy.
Patent EP-1421733-A2 (EP)
Title: Method for encoding and decoding communication data
Inventor: FELLERER JOSEF
IPC: H04L9/08
Filed: 2002-08-01
Abstract: The invention relates to a method for encoding and decoding communication data (32), especially voice data, which is transmitted in a plurality of data packets (30) in a digital communication network (1), especially for internet telephony. The communication data (32) is encoded by means of a selected code at an emission point (2, 3, 4) in each of the data packets (30); a code number of the selected code is transmitted as code information with each of the data packets; and the communication data (32) is decoded by allocating the code number to the code stored in the code table created at a reception point (2, 3, 4).
Patent EP-1432431-A2 (EP)
Title: Methods and compositions for modulating interleukin-21 receptor activity
Inventor: CARTER LAURA
IPC: A61P19/02
Filed: 2002-10-04
Abstract: Methods and compositions for modulating interleukin-21 (IL-21)/IL-21 receptor (MU-1) activity using agonists or antagonists of IL-21 or IL-21 receptor ('IL-21R' or 'MU-1'), are disclosed. IL-21/IL-21R antagonists can be used to induce immune suppression in vivo, e.g., for treating or preventing immune cell-associated pathologies (e.g., pathologies associated with aberrant activity of one or more of mature T cells (mature CD8+, mature CD4+ T cells), mature NK cells, B cells, macrophages and megakaryocytes, including transplant rejection and autoimmune disorders). IL-21/IL-21R agonists can be used by themselves or in combination with an antigen, e.g., as an adjuvant (e.g., a vaccine adjuvant), to up-regulate an immune response in vivo, e.g., for example, for use in treating cancer and infectious disorders.
Patent EP-1414522-A2 (EP)
Inventor: O'NEAL JANET M
IPC: A61P27/06
Filed: 2002-08-09
Abstract: L'invention concerne des méthodes permettant de traiter ou de prévenir des troubles ou des maladies associés à l'anhydrase carbonique chez un sujet ayant besoin d'utiliser un traitement comme prévention. Lesdites méthodes consistent à administrer des inhibiteurs de cyclooxygénase -2 ou des composés structurellement associés possédant des propriétés inhibitrices d'anhydrase carbonique ainsi que des combinaisons d'inhibiteurs de cyclooxygénase -2 ou de composés structurellement associés, et d'agents ou de médicaments anti-inflammatoires, antinéoplastes ou ophtalmiques dans des méthodes de traitement ou de prévention de troubles et de maladies.
Patent EP-1458409-A2 (EP)
Inventor: WEICH NADINE S
IPC: G01N33/573
Filed: 2002-10-08
Abstract: L'invention concerne des molécules d'acides nucléiques isolées, appelées molécules d'acides nucléiques 14081, qui codent de nouveaux membres de la famille des sérines protéases humaines de type trypsine. Elle concerne également des molécules d'acides nucléiques antisens, des vecteurs d'expression recombinés contenant des molécules d'acides nucléiques 14081 isolées, des cellules hôtes dans lesquelles les vecteurs d'expression ont été introduits, et des animaux transgéniques non humains dans lesquels un gène 14081 a été introduit ou disloqué. L'invention concerne en outre des protéines 14081 isolées, des protéines de fusion, des peptides antigéniques et des anticorps anti-14081. Elle concerne enfin des méthodes diagnostiques et thérapeutiques mettant en oeuvre les compositions de l'invention.
Patent EP-1590647-A2 (EP)
Inventor: PINES ALEXANDER
IPC: G01R33/46
Filed: 2002-10-09
Abstract: An apparatus and method for remote NMR/MRI spectroscopy having an encoding Gail with a sample chamber, a supply of signal carriers, preferably hyperpolarized xenon and a detector allowing the spatial and temporal separation of signal preparation and signal detection steps, This separation allows the physical conditions and methods of the encoding and detection steps to be optimized independently. The encoding of the carrier molecules may take place in a high or a low magnetic field and conventional NMR pulse sequences can be split between encoding and detection steps. In one embodiment, the detector is a high magnetic field NMR apparatus. In another embodiment, the detector is a superconducting quantum interference device. A further embodiment uses optical detection of Rb-Xe spin exchange. Another embodiment uses an optical magnetometer using non-linear Faraday rotation. Concentration of the signal carriers in the detector can greatly improve the signal to noise ratio.
Patent EP-1444870-A2 (EP)
Inventor: ELMER HUBERT
IPC: E05D7/08
Filed: 2002-11-05
Abstract: The invention relates to a fitting system according to parent application DE 101 19 987.3 for rotatably bearing a door leaf ( 2 ) in a glass construction. A fitting ( 1 ) is disposed on the top and/or at the bottom of said door leaf ( 2 ) and interacts with a complementary counter-fitting. A bearing axis extends in the plane of the door leaf and every fitting ( 1 ) is subdivided longitudinally by an intermediate space ( 3 ), while forming opposite bearing surfaces ( 7, 8 ), into at least partially spaced-apart fitting elements ( 4, 5 ) that can be disposed in a form-fit in a recess ( 9 ) of the door leaf ( 2 ). In order to stabilize the fitting system and to provide tamper-proof and protected fittings ( 1 ) that are also optically appealing, the fitting elements ( 4, 5 ) are fastened to the door leaf ( 2 ) by means of pins ( 16, 17 ) that are introduced at an angle to the longitudinal direction in through bores ( 14, 15 ) and in blind bores ( 12, 13 ) of the two fitting elements ( 4,5 ), while reducing the intermediate space ( 3 ). A rod stud ( 27 ) fastened to the one fitting elements ( 5 ) accommodates the two insertable pins ( 16, 17 ) while capping them, said rod stud ( 27 ) extending in parallel to the plane of the door leaf.
Patent EP-1331294-A2 (EP)
Inventor: HASEGAWA HIROAKI
IPC: D03D51/00
Filed: 2003-01-22
Abstract: An electric selvage device control method times the
selvage shed closing operation of an electric selvage device
(3) to close a selvage shed (18) of selvage yarns (17) by the
electric selvage device (3) at an optimum phase of a weaving
cycle. A sensor (25, 26, 27, 44, 45) provides a detection
signal upon the detection of the passage of a picked weft yarn
(2) by a predetermined position. The electric selvage device
(3) is driven on the basis of the detection signal for the
selvage shed closing operation to grip the picked weft yarn
(2) by the selvage yarns (17) without obstructing the travel
of the picked weft yarn (2)at the earliest possible phase of
the weaving cycle.